Clinical Trial Update: Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials evaluated dose-response and variability of inhaled insulin in Type 2 Diabetes Mellitus and have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin)

Snippet

Sponsor: Dance Biopharm Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED